Annual report
9470.TEDINET S100SIWK
Period2022-10-01 → 2023-09-30
Filed2023-12-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥164.1bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥156.0bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥150.3bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥143.6bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥140.6bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥6.2bn | 2022-10-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥6.4bn | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥6.5bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.9bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.1bn | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.3bn | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.8bn | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.7bn | 2022-10-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥6.4bn | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.2bn | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.4bn | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.3bn | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.6bn | 2022-10-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥136.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥123.7bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥116.9bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥103.7bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥99.3bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥74.8bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥55.0bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥47.4bn | at 2021-09-30d | Cons. | Net assets |
| Net assets / equity | ¥36.2bn | at 2020-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥40.0bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.9bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥24.8bn | at 2020-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥19.8bn | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.5bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.2bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.4bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.0bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.4bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥4.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.8bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥18.1bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.8bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.0bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥7.8bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥22m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥352m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥72.51 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.67 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.55 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.7 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.18 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥71.9 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥77.95 | 2021-10-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥63.87 | 2020-10-01 → 2021-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.99 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51.63 | 2018-10-01 → 2019-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,195.91 | at 2023-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,102.16 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,079.09 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥967.7 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,040.65 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 38.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.6% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.3% | 2022-10-01 → 2023-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2020-10-01 → 2021-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.0% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 9,490 | at 2023-09-30 | Cons. | Number of employees |
| Employees | 8,341 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 7,995 | at 2021-09-30d | Cons. | Number of employees |
| Employees | 7,690 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 6,970 | at 2019-09-30d | Cons. | Number of employees |
| Revenue | ¥7.5bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥5.0bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥4.6bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.6bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.5bn | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Operating income | ¥55m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Ordinary income | ¥2.1bn | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥450m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | −¥16m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥278m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥671m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.2bn | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥145m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Net income | ¥1.5bn | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | ¥60m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥330m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥740m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥631m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥86.2bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥78.5bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥76.4bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥64.8bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥59.0bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥47.5bn | at 2023-09-30 | Standalone | Liabilities |
| Total liabilities | ¥41.5bn | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥38.8bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥37.0bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥38.5bn | at 2021-09-30d | Standalone | Net assets |
| Net assets / equity | ¥30.0bn | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥30.3bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2022-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥33.8 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.38 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.14 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.99 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.99 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥33.51 | 2022-10-01 → 2023-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1.36 | 2021-10-01 → 2022-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.05 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.77 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.81 | 2018-10-01 → 2019-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥25 | 2022-10-01 → 2023-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2021-10-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2020-10-01 → 2021-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥75 | 2018-10-01 → 2019-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥873.49 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥836.74 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥879 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥802.24 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥814.75 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 44.7% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.9% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.0% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.0% | 2022-10-01 → 2023-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.2% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.0% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.5% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.0% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 44,633,232 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,633,232 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,633,232 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 42,383,232 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,595,808 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 60 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 58 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 57 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 41 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 44 | at 2019-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 85
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-10-01 → 2023-09-30 | ¥92m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-10-01 → 2023-09-30 | ¥248m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-09-30 | 422 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-10-01 → 2023-09-30 | ¥15.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-10-01 → 2023-09-30 | ¥6.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥9.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-09-30 | ¥8.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-10-01 → 2023-09-30 | ¥401m |
| Reconciling Itemsreconciling | capex | 2022-10-01 → 2023-09-30 | ¥10m |
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | ¥50m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-09-30 | −¥9.6bn |
| Reconciling Itemsreconciling | segment assets | at 2023-09-30 | ¥23.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | −¥2.0bn |
| Educationreportable segment | capex | 2022-10-01 → 2023-09-30 | ¥1.5bn |
| Educationreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥1.2bn |
| Educationreportable segment | employees | at 2023-09-30 | 3465 pure |
| Educationreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥79.8bn |
| Educationreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥79.5bn |
| Educationreportable segment | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥361m |
| Educationreportable segment | segment assets | at 2023-09-30 | ¥55.0bn |
| Educationreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥3.9bn |
| Medical Welfarereportable segment | capex | 2022-10-01 → 2023-09-30 | ¥771m |
| Medical Welfarereportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥848m |
| Medical Welfarereportable segment | employees | at 2023-09-30 | 5543 pure |
| Medical Welfarereportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥78.7bn |
| Medical Welfarereportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥78.6bn |
| Medical Welfarereportable segment | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥81m |
| Medical Welfarereportable segment | segment assets | at 2023-09-30 | ¥49.4bn |
| Medical Welfarereportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥3.8bn |
| —segment total | capex | 2022-10-01 → 2023-09-30 | ¥2.2bn |
| —segment total | depreciation | 2022-10-01 → 2023-09-30 | ¥2.0bn |
| —segment total | revenue | 2022-10-01 → 2023-09-30 | ¥158.5bn |
| —segment total | revenue external | 2022-10-01 → 2023-09-30 | ¥158.1bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥442m |
| —segment total | segment assets | at 2023-09-30 | ¥104.4bn |
| —segment total | segment profit | 2022-10-01 → 2023-09-30 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-10-01 → 2023-09-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-10-01 → 2023-09-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-09-30 | ¥173.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-09-30 | ¥164.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-09-30 | ¥113.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-09-30 | ¥8.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-10-01 → 2022-09-30 | ¥242m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-10-01 → 2022-09-30 | ¥306m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-10-01 → 2022-09-30 | ¥13.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-10-01 → 2022-09-30 | ¥5.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥8.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-09-30 | ¥5.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-10-01 → 2022-09-30 | ¥805m |
| Reconciling Itemsreconciling | capex | 2021-10-01 → 2022-09-30 | ¥52m |
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥66m |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-09-30 | −¥8.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-09-30 | −¥8.6bn |
| Reconciling Itemsreconciling | segment assets | at 2022-09-30 | ¥20.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥2.0bn |
| Educationreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Educationreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥1.2bn |
| Educationreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥78.4bn |
| Educationreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥78.2bn |
| Educationreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥246m |
| Educationreportable segment | segment assets | at 2022-09-30 | ¥49.9bn |
| Educationreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥4.4bn |
| Medical Welfarereportable segment | capex | 2021-10-01 → 2022-09-30 | ¥1.6bn |
| Medical Welfarereportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥595m |
| Medical Welfarereportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥72.3bn |
| Medical Welfarereportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥72.2bn |
| Medical Welfarereportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥50m |
| Medical Welfarereportable segment | segment assets | at 2022-09-30 | ¥47.7bn |
| Medical Welfarereportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥3.1bn |
| —segment total | capex | 2021-10-01 → 2022-09-30 | ¥2.7bn |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥1.8bn |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥150.7bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥150.4bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥297m |
| —segment total | segment assets | at 2022-09-30 | ¥97.6bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥7.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-10-01 → 2022-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-10-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-09-30 | ¥164.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥156.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-09-30 | ¥103.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-09-30 | ¥8.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,783
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_NonControllingInterestsMember | 2056000000 | JPY |
| Net assets | CurrentYearInstant | 55034000000 | JPY |
| Income before income taxes | Prior1YearDuration | 6445000000 | JPY |
| Income before income taxes | CurrentYearDuration | 6705000000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 2140000000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 2333000000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | 696000000 | JPY |
| Impairment loss ope cf | CurrentYearDuration | 103000000 | JPY |
| Amortization of goodwill ope cf | Prior1YearDuration | 888000000 | JPY |
| Amortization of goodwill ope cf | CurrentYearDuration | 818000000 | JPY |
| Loss gain on sales and retirement of property plant and equipment and intangible assets ope cf | Prior1YearDuration | 48000000 | JPY |
| Loss gain on sales and retirement of property plant and equipment and intangible assets ope cf | CurrentYearDuration | -411000000 | JPY |
| Loss gain on sales and valuation of investment securities ope cf | Prior1YearDuration | -280000000 | JPY |
| Loss gain on sales and valuation of investment securities ope cf | CurrentYearDuration | 620000000 | JPY |
| Loss gain on step acquisitions ope cf | Prior1YearDuration | － | JPY |
| Loss gain on step acquisitions ope cf | CurrentYearDuration | -741000000 | JPY |
| Increase decrease in provision ope cf | Prior1YearDuration | -676000000 | JPY |
| Increase decrease in provision ope cf | CurrentYearDuration | -102000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | Prior1YearDuration | -699000000 | JPY |
| Increase decrease in net defined benefit asset ope cf | CurrentYearDuration | -289000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YearDuration | 28000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYearDuration | 74000000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -206000000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -207000000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 179000000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 225000000 | JPY |
| Commission fee ope cf | Prior1YearDuration | 84000000 | JPY |
| Commission fee ope cf | CurrentYearDuration | 66000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | -304000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | -347000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -1119000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | 295000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -950000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -41000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | -414000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | -399000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YearDuration | 149000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYearDuration | -32000000 | JPY |
| Decrease increase in other assets ope cf | Prior1YearDuration | -633000000 | JPY |
| Decrease increase in other assets ope cf | CurrentYearDuration | -76000000 | JPY |
| Increase decrease in other liabilities ope cf | Prior1YearDuration | 861000000 | JPY |
| Increase decrease in other liabilities ope cf | CurrentYearDuration | 1292000000 | JPY |
| Other net ope cf | Prior1YearDuration | 89000000 | JPY |
| Other net ope cf | CurrentYearDuration | 260000000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 6327000000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 10146000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 367000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 409000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -179000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -225000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |